Pay in 4 interest-free payments of $7.17 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Research Compound Summary Compound: TB-500 (Thymosin Beta-4 Fragment) CAS Number: 77591-33-4 Molecular Formula: C212H350N56O78S Purity: 98.62% (HPLC-UV verified) Third-Party Testing: Testides Analytical (independent lab, Toronto) COA Download: View Full COA (PDF) Report: DBAV-TB500-10-051226 Source: Canadian manufactured Shipping: Same-day from our BC facility TB-500 peptide Canada: a synthetic version of a 43-amino acid region of Thymosin Beta-4 (TB4), a naturally occurring protein involved in cell migration and differentiation research
Experts recommend the use of bacteriostatic water for this purpose
Neither BPC-157 nor TB-500 is an approved medicine in Australia - neither is on the Australian Register of Therapeutic Goods, and the TGA has not evaluated either for safety, quality or effectiveness
While animal models suggest that BPC-157 can help heal everything from ulcers, wounds, and burns to ligament, tendon, and muscle injuries, randomized trial evidence is nowhere to be found
Administer the Injection Hold the syringe like a dart
Regeno Blend (BPC-157, TB-500, Cartalax) 30mg REGENO Cartalax + TB-500 + BPC-157 is a triple-peptide research formulation utilized in preclinical research involving tissue-associated signaling, extracellular matrix organization, cellular migration dynamics, and cartilage-related regulatory pathways
